creating

The GLP-1 gold rush is creating winners far beyond pharma

Every month, sales executive Kelly Freeman spends about $112 on Ozempic, which he started taking in 2024 for diabetes. The drug is one line item in a long list of GLP-related costs. Loading audio narration… There are supplements, an Apple watch, a life coach, a functional physician, healthier foods, and…

Google Deepmind CEO says the memory shortage is creating an AI ‘choke point’

The memory shortage takes no prisoners. Even Google isn’t immune.AI companies are duking it out for greater and greater quantities of memory chips. The problem? The industry is heavily supply-constrained. Costs have skyrocketed, products have been tied up, and some companies — especially those in consumer electronics — are increasing…